Did you know?

Potential Savara Inc. (NASDAQ:SVRA) shareholders may wish to note that the Independent Director, David Ramsay, recently bought US$142k worth of stock, paying US$1.42 for each share.Every investor in Savara Inc. (NASDAQ:SVRA) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are private equity firms with 41% ownership.Savara ; Year invested 2021 ; Investment Stage Public/PIPES ; Company Status IPO/Public (NASDAQ: SVRA).Savara Inc. Follow. Share. $3.63. Nov 24, 3:06:20 AM GMT-5 · USD · NASDAQ · Disclaimer. search Compare to. Ardelyx Inc. $4.31. AUSTIN, Texas, April 27, 2017 /PRNewswire/ -- Savara Inc. (NASDAQ: SVRA ), a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for ...What is Savara's consensus rating and price target? According to the issued ratings of 3 analysts in the last year, the consensus rating for Savara stock is Buy based on the current 3 buy ratings for SVRA. The average twelve-month price prediction for Savara is $5.67 with a high price target of $7.00 and a low price target of $4.00.Nov 13, 2023 · 4. Savara, Inc. (NASDAQ:SVRA) Farallon Capital Equity Stake: $34.85 Million. Number of Hedge Fund Holders: 10. Headquartered in Austin, Texas, Savara, Inc. (NASDAQ:SVRA) develops inhaled therapies ... Savara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants. LANGHORNE, Pa.-- (BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the pricing of an underwritten offering of... 4 months ago - …October 20, 2023 at 10:58 AM EDT. Savara Inc. (NASDAQ: SVRA) is the focus of IBN’s latest stock spotlight. The company’s shares have moved 2.67% on the day to $3.27. Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage ...We have not taken an in-depth look at Savara (NASDAQ:SVRA) since our last article on this small developmental concern back in May of 2021. The stock has been in a trading range since early 2020 ...... (NASDAQ: SVRA), and Tenacia. Previously he was a board member of Arcutis (NASDAQ: ARQT), Annexon (NASDAQ: ANNX), and served as board observer of Pharvaris ...Savara Inc (NASDAQ:SVRA) 3.74. Delayed Data. As of 3:59pm ET. +0.01 / +0.27%. Today’s Change. 1.32. Today ||| 52-Week Range. 4.21.Savara has generated ($0.31) earnings per share over the last year ( ($0.31) diluted earnings per share). Earnings for Savara are expected to remain at ($0.35) per …8 nov 2023 ... Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its ...finance.yahoo.com - February 14 at 8:56 AM. Private equity firms are Savara Inc.'s (NASDAQ:SVRA) biggest owners and were rewarded after market cap rose by US$25m last week. finance.yahoo.com - January 5 at 8:46 AM. Insider Buying: Savara Inc (NASDAQ:SVRA) Director Purchases 41,414 Shares of Stock. marketbeat.com - December 22 at 6:33 PM.SVRA Related ETFs ; Total Stock Market ETF Vanguard ; IWN, 0.Every investor in Savara Inc. (NASDAQ:SVRA) should be awa Find the latest SEC Filings data for Savara Inc. Common Stock (SVRA) at Nasdaq.com. Hedge fund activity in Savara, Inc. (NASDAQ:SVRA) At Q Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to three new employees. On October 3, 2023, the Compensation Committee of Savara's Board of Directors granted the inducement awards to three new employees who recently joined the Company.May 16, 2023 · Savara ( NASDAQ: SVRA ), a biotech focused on respiratory disorders, added ~7% pre-market Tuesday after Jefferies upgraded its shares to Buy from Hold citing over 100% upside in the event of a ... Savara Inc. Follow. Share. $3.63. Nov 24, 3:06:20 AM GMT-5 · U

Savara Inc. (NASDAQ: SVRA) is the focus of IBN’s latest stock spotlight. The company’s shares have moved 5.92% on the day to $3.67. Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is ...SVRA. Savara Inc. 3.8000. +0.1700. +4.68%. In this article, we will take a look at the 15 penny stocks with biggest upside. To see more such companies, go directly to 5 Penny Stocks with Biggest ...Savara Inc (NASDAQ:SVRA)’s traded shares stood at 0.37 million during the last session, with the company’s beta value hitting 0.75. At the close of trading, the stock’s price was $3.79, to imply an increase of 4.41% or $0.16 in intraday trading. The SVRA share’s 52-week high remains $4.21, putting it -11.08% down since that peak but ...LANGHORNE, Pa., November 09, 2023--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the ...Try our new Technical Analysis Screener >. Savara ’s ( SVRA) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Savara is a Sell. Savara ’s ( SVRA) 20-Day exponential moving average is 3.64, while Savara ’s ( SVRA) share price is $3.79, making it a Sell.

Price. %Change. SVRA. 3.900. +1.30%. paper trading platform. Webull offers SVRA Ent Holdg (SVRA) historical stock prices, in-depth market analysis, NASDAQ: SVRA real-time stock quote data, in-depth charts, free SVRA options chain data, and a fully built financial calendar to help you invest smart. Buy SVRA stock at Webull.From a technical perspective, Savara Inc. (SVRA) is looking like an interesting pick, as it just reached a key level of support. SVRA's 50-day simple moving average crossed above its 200-day ...Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to three new employees. On October 3, 2023, the Compensation Committee of Savara's Board of Directors granted the inducement awards to three new employees who recently joined ……

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Research Savara's (Nasdaq:SVRA) stock key. Possible cause: Research Savara's (Nasdaq:SVRA) stock key valuation metrics while comparing.